(Q33179434)

23 July 2017

1 reference

title

Chronic fatigue syndrome: reviewing the research findings (English)

1 reference

23 July 2017

main subject

chronic fatigue syndrome

1 reference

Johnson SK

1

1 reference

23 July 2017

DeLuca J

series ordinal

2

1 reference

23 July 2017

Natelson BH

series ordinal

3

1 reference

23 July 2017

publication date

1 January 1999

1 reference

Annals of Behavioral Medicine

23 July 2017

published in

1 reference

23 July 2017

volume

21

1 reference

23 July 2017

issue

3

1 reference

23 July 2017

page(s)

258-271

1 reference

Neurasthenia in the 1980s: chronic mononucleosis, chronic fatigue syndrome, and anxiety and depressive disorders

23 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Chronic fatigue syndrome: a working case definition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

The prognosis of chronic fatigue and chronic fatigue syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Depression in patients with neuromyasthenia (benign myalgic encephalomyelitis).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Postviral fatigue syndrome: time for a new approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Culture and somatic experience: the social course of illness in neurasthenia and chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Reducing heterogeneity in chronic fatigue syndrome: a comparison with depression and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Behavioural problems associated with the chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Neuropsychological and psychiatric abnormalities in myalgic encephalomyelitis: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Attention and short-term memory in chronic fatigue syndrome patients: an event-related potential analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Information processing efficiency in chronic fatigue syndrome and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Cognitive functioning of patients with chronic fatigue syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Cognitive functioning and depression in patients with chronic fatigue syndrome and multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Quality of attention in chronic fatigue syndrome: subjective reports of everyday attention and cognitive difficulty, and performance on tasks of focused attention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Selective impairment of auditory processing in chronic fatigue syndrome: a comparison with multiple sclerosis and healthy controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Prevalence of IgM Antibodies to Human Herpesvirus 6 Early Antigen (p41/38) in Patients with Chronic Fatigue Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Seroepidemiology of chronic fatigue syndrome: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Post-infection fatigue syndrome following Q fever.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Elevated apoptotic cell population in patients with chronic fatigue syndrome: the pivotal role of protein kinase RNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

A Chronic Illness Characterized by Fatigue, Neurologic and Immunologic Disorders, and Active Human Herpesvirus Type 6 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Increased brain serotonin function in men with chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

A controlled clinical trial with a specifically configured RNA drug, poly(I).poly(C12U), in chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Putting the rest cure to rest--again

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Cognitive behaviour therapy for the chronic fatigue syndrome: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

Professional and popular views of chronic fatigue syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02884843

21 January 2018

Identifiers

DOI

10.1007/BF02884843

1 reference

23 July 2017

1 reference